RSKD vs IBTA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
RSKD · Riskified$8.54 ▲ 2.77%
IBTA · Ibotta$58.11 ▲ 0.45%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- RSKD +77.5%
- IBTA +104.9%
Head to head
| Metric | RSKD | IBTA |
|---|---|---|
| Price | $8.54 | $58.11 |
| Change today | ▲ 2.77% | ▲ 0.45% |
| Market cap | $1.13B | $1.36B |
| Return, 3 months | +60.5% | +60.6% |
| Return, year to date | +71.8% | +155.7% |
| Return, 1 year | +78.7% | +106.0% |
| P/E (TTM) | – | – |
| P/B | 5.4 | 5.7 |
| P/E percentile vs own 5y | 1st | 3rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +21.8% | +3.3% |
| Net profit growth (YoY) | +21.7% | -149.4% |
| Gross margin | 51.3% | 78.2% |
| Operating margin | -4.7% | -3.5% |
| Net margin | -4.2% | -3.2% |
| Return on equity | -5.7% | -3.7% |
| Analyst target vs. price | -5.6% | -38.0% |
| Analyst buy share | 60% | 25% |
| RSI (14) | 53 | 70 |
| 30-day volatility | 46.9% | 71.1% |
| Max drawdown, 1 year | -25.4% | -45.1% |
| Trend read | Leaning bullish | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IBTA is the largest of the group by market value.
- IBTA has returned the most over the past year.
- RSKD is growing revenue fastest.
- IBTA keeps the most profit per dollar of sales.
- RSKD has been the calmest stock over the last 30 days.